Reversible ageusia associated with losartan. 1996

R G Schlienger, and M Saxer, and W E Haefeli

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000370 Ageusia Complete or severe loss of the subjective sense of taste, frequently accompanied by OLFACTION DISORDERS. Ageusia, Hysterical,Hypogeusia,Loss of Taste,Taste-Blindness,Ageusias, Hysterical,Hypogeusias,Hysterical Ageusia,Hysterical Ageusias,Taste Blindness,Taste Loss
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl
D013777 Tetrazoles
D057911 Angiotensin Receptor Antagonists Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR. Angiotensin II Receptor Antagonist,Angiotensin II Receptor Blocker,Angiotensin Receptor Antagonist,Angiotensin Receptor Blocker,Angiotensin II Receptor Antagonists,Angiotensin II Receptor Blockers,Angiotensin Receptor Blockers,Antagonist, Angiotensin Receptor,Antagonists, Angiotensin Receptor,Blocker, Angiotensin Receptor,Receptor Antagonist, Angiotensin,Receptor Antagonists, Angiotensin,Receptor Blocker, Angiotensin,Receptor Blockers, Angiotensin

Related Publications

R G Schlienger, and M Saxer, and W E Haefeli
May 2002, European journal of neurology,
R G Schlienger, and M Saxer, and W E Haefeli
June 2006, Neurology India,
R G Schlienger, and M Saxer, and W E Haefeli
September 2012, Revista medica de Chile,
R G Schlienger, and M Saxer, and W E Haefeli
September 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
R G Schlienger, and M Saxer, and W E Haefeli
November 1983, Deutsche medizinische Wochenschrift (1946),
R G Schlienger, and M Saxer, and W E Haefeli
January 2004, The Annals of pharmacotherapy,
R G Schlienger, and M Saxer, and W E Haefeli
February 1989, Clinical pharmacy,
R G Schlienger, and M Saxer, and W E Haefeli
January 2010, Reumatologia clinica,
R G Schlienger, and M Saxer, and W E Haefeli
February 2000, Lancet (London, England),
R G Schlienger, and M Saxer, and W E Haefeli
January 1996, Cardiology,
Copied contents to your clipboard!